Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market
—·4h
The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
TickersGLPChannelsstocksCountriesusaCategoriespharma
Open original source ↗Published
7/21/2026, 3:02:00 PM
Fetched
7/21/2026, 3:07:09 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en